203 related articles for article (PubMed ID: 29420864)
1. Preparation of Tetradentate Copper Chelators as Potential Anti-Alzheimer Agents.
Zhang W; Huang D; Huang M; Huang J; Wang D; Liu X; Nguyen M; Vendier L; Mazères S; Robert A; Liu Y; Meunier B
ChemMedChem; 2018 Apr; 13(7):684-704. PubMed ID: 29420864
[TBL] [Abstract][Full Text] [Related]
2. Characterization of new specific copper chelators as potential drugs for the treatment of Alzheimer's disease.
Nguyen M; Robert A; Sournia-Saquet A; Vendier L; Meunier B
Chemistry; 2014 May; 20(22):6771-85. PubMed ID: 24797103
[TBL] [Abstract][Full Text] [Related]
3. N
Zhang W; Liu Y; Hureau C; Robert A; Meunier B
Chemistry; 2018 Jun; 24(31):7825-7829. PubMed ID: 29687932
[TBL] [Abstract][Full Text] [Related]
4. Transfer of Copper from an Amyloid to a Natural Copper-Carrier Peptide with a Specific Mediating Ligand.
Nguyen M; Bijani C; Martins N; Meunier B; Robert A
Chemistry; 2015 Nov; 21(47):17085-90. PubMed ID: 26420347
[TBL] [Abstract][Full Text] [Related]
5. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.
Robert A; Liu Y; Nguyen M; Meunier B
Acc Chem Res; 2015 May; 48(5):1332-9. PubMed ID: 25946460
[TBL] [Abstract][Full Text] [Related]
6. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
7. Importance of the Dimethylamino Functionality on a Multifunctional Framework for Regulating Metals, Amyloid-β, and Oxidative Stress in Alzheimer's Disease.
Derrick JS; Kerr RA; Korshavn KJ; McLane MJ; Kang J; Nam E; Ramamoorthy A; Ruotolo BT; Lim MH
Inorg Chem; 2016 May; 55(10):5000-13. PubMed ID: 27119456
[TBL] [Abstract][Full Text] [Related]
8. Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy.
Deraeve C; Boldron C; Maraval A; Mazarguil H; Gornitzka H; Vendier L; Pitié M; Meunier B
Chemistry; 2008; 14(2):682-96. PubMed ID: 17969218
[TBL] [Abstract][Full Text] [Related]
9. Copper(I) Chelators for Alzheimer's Disease.
Opare SKA; Rauk A
J Phys Chem B; 2017 Dec; 121(50):11304-11310. PubMed ID: 29172520
[TBL] [Abstract][Full Text] [Related]
10. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
11. Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease.
Huang L; Lu C; Sun Y; Mao F; Luo Z; Su T; Jiang H; Shan W; Li X
J Med Chem; 2012 Oct; 55(19):8483-92. PubMed ID: 22978824
[TBL] [Abstract][Full Text] [Related]
12. Two pyridine derivatives as potential Cu(II) and Zn(II) chelators in therapy for Alzheimer's disease.
Lakatos A; Zsigó E; Hollender D; Nagy NV; Fülöp L; Simon D; Bozsó Z; Kiss T
Dalton Trans; 2010 Feb; 39(5):1302-15. PubMed ID: 20104357
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.
Storr T; Merkel M; Song-Zhao GX; Scott LE; Green DE; Bowen ML; Thompson KH; Patrick BO; Schugar HJ; Orvig C
J Am Chem Soc; 2007 Jun; 129(23):7453-63. PubMed ID: 17511455
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
Peng YB; Tao C; Tan CP; Zhao P
J Inorg Biochem; 2021 Nov; 224():111591. PubMed ID: 34450410
[TBL] [Abstract][Full Text] [Related]
15. Sulfur-bridging the gap: investigating the electrochemistry of novel copper chelating agents for Alzheimer's disease applications.
Crnich E; Sanchez E; Havens MA; Kissel DS
J Biol Inorg Chem; 2023 Oct; 28(7):643-653. PubMed ID: 37594567
[TBL] [Abstract][Full Text] [Related]
16. Liberation of copper from amyloid plaques: making a risk factor useful for Alzheimer's disease treatment.
Geng J; Li M; Wu L; Ren J; Qu X
J Med Chem; 2012 Nov; 55(21):9146-55. PubMed ID: 22663067
[TBL] [Abstract][Full Text] [Related]
17. Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.
Jiang D; Men L; Wang J; Zhang Y; Chickenyen S; Wang Y; Zhou F
Biochemistry; 2007 Aug; 46(32):9270-82. PubMed ID: 17636872
[TBL] [Abstract][Full Text] [Related]
18. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
Tahmasebinia F; Emadi S
Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098
[TBL] [Abstract][Full Text] [Related]
19. Histidine availability is decisive in ROS-mediated cytotoxicity of copper complexes of Aβ1-16 peptide.
Ginotra YP; Ramteke SN; Walke GR; Rapole S; Kulkarni PP
Free Radic Res; 2016; 50(4):405-13. PubMed ID: 26690929
[TBL] [Abstract][Full Text] [Related]
20. Potential molecular and graphene oxide chelators to dissolve amyloid-β plaques in Alzheimer's disease: a density functional theory study.
Liu C; Luo X
J Mater Chem B; 2021 Mar; 9(11):2736-2746. PubMed ID: 33688880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
